BPC-157 Review: What Research Shows About This Healing Peptide
BPC-157 is one of the most discussed “healing” peptides. Here’s what the evidence actually supports — and what it doesn’t. Research and preclinical reference only.
The Short Answer
BPC-157 is a synthetic peptide derived from a protective protein found in gastric juice, and preclinical studies suggest it promotes healing in muscle, tendon, and gut tissue — but it has no human approval and most evidence is animal-based. The gap between preclinical promise and human data is the thing to keep in mind.
Where It Comes From
BPC-157 is a 15-amino-acid fragment of a body protection compound (BPC) originally isolated from gastric juice, and that origin is why gut-health and tissue-repair research both focus on it. Its name literally encodes the “body protection compound” source.
- Class: synthetic peptide fragment (15 amino acids)
- Origin: gastric juice protective protein
- Studied for: tendon, muscle, and gut tissue repair
What the Studies Show
Animal studies report accelerated healing in tendon, ligament, muscle, and GI tissue, but the human evidence is thin and mostly anecdotal — so BPC-157 remains a preclinical research compound, not an approved therapy. The mechanism (angiogenesis and growth-factor modulation) is proposed, not fully proven in humans.
Sourcing and Purity
Research-grade BPC-157 should be ≥98% pure by HPLC with mass spectrometry confirmation and a batch-matched COA, and because it’s a popular and heavily counterfeited peptide, independent verification matters more than usual. This is one of the most-faked peptides on the market.
FAQ
Q: What is BPC-157 used for?
A: BPC-157 is a peptide studied in preclinical research for tissue healing in tendon, muscle, and the gut, but it has no human approval. It is research-use only.
Q: Is BPC-157 approved for human use?
A: No — BPC-157 has no regulatory approval for human use, and most evidence comes from animal studies. It is sold strictly as a research compound.
Q: How is BPC-157 different from TB-500?
A: BPC-157 is a gastric-derived peptide fragment studied for gut and soft-tissue repair, while TB-500 is a thymosin beta-4 fragment studied more for muscle and recovery — they’re often stacked in research but act differently. See our BPC-157 vs TB-500 comparison for detail.